Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Exocrine Pancreatic Insufficiency Market Growth Evolved From 2024 To 2025, And What’s Ahead?
Over the previous years, there has been substantial growth in the market size of exocrine pancreatic insufficiency. It is set to expand from $2.59 billion in 2024 to $2.75 billion in 2025, documenting a compound annual growth rate (CAGR) of 6.4%. This progression during the historical phase can be credited to a surge in awareness and detection, amplified prevalence of digestive diseases, an aging demographic, a decline in pancreatic function, and an increase in gastrointestinal surgical procedures.
In the forthcoming years, the market for exocrine pancreatic insufficiency is projected to experience substantial growth. It is expected that the market will expand to $3.59 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. The projected growth during the forecast period can be attributed to several factors such as growing awareness and screening, an increasing elderly population, rising occurrence of chronic ailments, enhanced access to healthcare for patients, and advancements in research and development for digestive health. Upcoming trends for the forecast period include improvements in telehealth and digital health solutions, cooperative research initiatives, increased focus on pediatric epi, regulatory progress and expedited designations, market expansion in emerging economies, and advancements in healthcare infrastructure.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp
What External and Internal Drivers Are Contributing to the Growth of theExocrine Pancreatic Insufficiency Market?
The growth of the exocrine pancreatic insufficiency market is projected to be stimulated by the escalating prevalence of chronic illnesses. These are long-lasting health conditions that endure for generally three months or more. The ongoing nature of such diseases often leads to an increased risk of secondary complications like exocrine pancreatic insufficiency, which justifies heightened management of chronic diseases through healthcare procedures and treatments, thus potentially extending the lifetimes of affected individuals. In fact, in September 2023, the World Health Organization – a specialized UN agency based in Switzerland – stated that annually, 41 million fatalities happen, out of which 74% are caused by non-communicable diseases (NCDs) or chronic diseases across the globe. Consequently, the surge in chronic diseases is expected to boost the growth of the exocrine pancreatic insufficiency market.
What Segment Types Define the Exocrine Pancreatic Insufficiency Market Structure?
The exocrine pancreatic insufficiencymarket covered in this report is segmented –
1) By Treatment: Nutritional Management; Pancreatic Enzyme Replacement Therapy (PERT); Other Treatments
2) By Diagnosis: Imaging Tests; Computed Tomography (CT) Scan; Abdominal Ultrasound; Secretin Pancreatic Function Test; Fecal Fat Test; Fecal Elastase Test (FE-1); Other Types
3) By Symptoms: Abdominal Pain; Constipation; Diarrhea; Fatty Stools; Weight Loss; Other Symptoms
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End Users: Hospitals; Specialty Clinics; Homecare
Subsegments:
1) By Nutritional Management: Dietary Modifications; Nutritional Supplements
2) By Pancreatic Enzyme Replacement Therapy (PERT): Enteric-Coated Capsules; Non-Enteric-Coated Capsules; Powder Formulations
3) By Other Treatments: Medications; Surgical Interventions; Supportive Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13107&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Exocrine Pancreatic Insufficiency Market?
North America was the largest region in the exocrine pancreatic insufficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Long-Term Trends Are Transforming the Competitive Landscape of the Exocrine Pancreatic Insufficiency Market?
Primary firms active in the exocrine pancreatic insufficiency marketplace are concentrating on forming patient advocacy organizations like comprehensive nutritional advice to deliver extensive nutritional monitoring and backing. These undertakings seek to boost familiarity, instruction, and control of the disorder amongst those impacted. Comprehensive nutritional counsel takes a complete view, customizing dietary suggestions grounded on singular necessities, health issues, and way of life. It highlights education, meal preparation, and lasting processes to advance total wellness. For example, Nestlé Health Science, a nutrition firm based in Switzerland, introduced a GLP-1 nutritional backing platform in June 2024. This platform from Nestlé Health Science offers personalized nutritional backing and expert counsel for individuals taking GLP-1 medicines, with an emphasis on muscle preservation, gut health, and overall fitness. Its objective is to empower consumers in their weight regulation journey by addressing specific dietary needs and fostering community support.
View the full report here:
What Is the Definition of the Exocrine Pancreatic Insufficiency Market?
Exocrine pancreatic insufficiency (EPI) is a medical condition characterized by the pancreas’s insufficient production or release of digestive enzymes into the small intestine. These enzymes are essential for the digestion and absorption of nutrients from food. Exocrine pancreatic insufficiency can lead to malnutrition and digestive symptoms, including diarrhea, abdominal pain, bloating, and weight loss.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13107
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model